Artyom Sedrakyan

Summary

Affiliation: Agency for Healthcare Research and Quality
Country: USA

Publications

  1. ncbi Improving depiction of benefits and harms: analyses of studies of well-known therapeutics and review of high-impact medical journals
    Artyom Sedrakyan
    Center for Outcomes and Evidence, Agency for Healthcare Research and Quality, Rockville, Maryland, USA
    Med Care 45:S23-8. 2007
  2. ncbi Off-pump surgery is associated with reduced occurrence of stroke and other morbidity as compared with traditional coronary artery bypass grafting: a meta-analysis of systematically reviewed trials
    Artyom Sedrakyan
    Center for Outcomes and Evidence, Agency for Healthcare Research and Quality, 540 Gaither Road, Rockville, MD 20850, USA
    Stroke 37:2759-69. 2006
  3. ncbi Cardiac device implantation in the United States from 1997 through 2004: a population-based analysis
    Chunliu Zhan
    Center for Outcomes and Evidence, Agency for Healthcare Research and Quality, Rockville, MD, USA
    J Gen Intern Med 23:13-9. 2008
  4. ncbi The risk of aprotinin: a conflict of evidence
    Artyom Sedrakyan
    Agency for Healthcare Research and Quality, Rockville, Maryland, USA
    Lancet 367:1376-7. 2006
  5. ncbi Effect of aprotinin on clinical outcomes in coronary artery bypass graft surgery: a systematic review and meta-analysis of randomized clinical trials
    Artyom Sedrakyan
    Yale University School of Medicine, New Haven, Conn, USA
    J Thorac Cardiovasc Surg 128:442-8. 2004
  6. ncbi Pharmacologic prophylaxis for postoperative atrial tachyarrhythmia in general thoracic surgery: evidence from randomized clinical trials
    Artyom Sedrakyan
    Clinical Effectiveness Unit, Royal College of Surgeons of England, London, 35 43 Lincoln s Inn Fields, London WC2A 3PE, England, UK
    J Thorac Cardiovasc Surg 129:997-1005. 2005
  7. ncbi Improving clinical outcomes in coronary artery bypass graft surgery
    Artyom Sedrakyan
    Johns Hopkins Bloomberg School of Public Health, 624 North Broadway, Suite 492, Baltimore, MD 21205, USA
    Am J Health Syst Pharm 62:S19-23. 2005
  8. ncbi Surgeons may have introduced a new operative technique in African-American patients
    Tom Treasure
    J Health Serv Res Policy 12:2-3. 2007
  9. ncbi The evidence on the effectiveness of management for malignant pleural effusion: a systematic review
    Carol Tan
    Thoracic Unit, Guy's Hospital, St Thomas' Street, London SE1 9RT, United Kingdom
    Eur J Cardiothorac Surg 29:829-38. 2006
  10. ncbi Recursive partitioning-based preoperative risk stratification for atrial fibrillation after coronary artery bypass surgery
    Artyom Sedrakyan
    Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA
    Am Heart J 151:720-4. 2006

Detail Information

Publications14

  1. ncbi Improving depiction of benefits and harms: analyses of studies of well-known therapeutics and review of high-impact medical journals
    Artyom Sedrakyan
    Center for Outcomes and Evidence, Agency for Healthcare Research and Quality, Rockville, Maryland, USA
    Med Care 45:S23-8. 2007
    ..Currently, even in the highest impact medical journals, evidence of benefits and harms is not consistently presented in ways that facilitate accurate interpretation...
  2. ncbi Off-pump surgery is associated with reduced occurrence of stroke and other morbidity as compared with traditional coronary artery bypass grafting: a meta-analysis of systematically reviewed trials
    Artyom Sedrakyan
    Center for Outcomes and Evidence, Agency for Healthcare Research and Quality, 540 Gaither Road, Rockville, MD 20850, USA
    Stroke 37:2759-69. 2006
    ..We sought to determine whether off-pump surgery is associated with reduced occurrence of adverse outcomes as compared with CABG with CPB...
  3. ncbi Cardiac device implantation in the United States from 1997 through 2004: a population-based analysis
    Chunliu Zhan
    Center for Outcomes and Evidence, Agency for Healthcare Research and Quality, Rockville, MD, USA
    J Gen Intern Med 23:13-9. 2008
    ..This study used hospital administrative data to assess cardiac device implantations in the United States, selected perioperative outcomes, and associated patient and hospital characteristics...
  4. ncbi The risk of aprotinin: a conflict of evidence
    Artyom Sedrakyan
    Agency for Healthcare Research and Quality, Rockville, Maryland, USA
    Lancet 367:1376-7. 2006
  5. ncbi Effect of aprotinin on clinical outcomes in coronary artery bypass graft surgery: a systematic review and meta-analysis of randomized clinical trials
    Artyom Sedrakyan
    Yale University School of Medicine, New Haven, Conn, USA
    J Thorac Cardiovasc Surg 128:442-8. 2004
    ....
  6. ncbi Pharmacologic prophylaxis for postoperative atrial tachyarrhythmia in general thoracic surgery: evidence from randomized clinical trials
    Artyom Sedrakyan
    Clinical Effectiveness Unit, Royal College of Surgeons of England, London, 35 43 Lincoln s Inn Fields, London WC2A 3PE, England, UK
    J Thorac Cardiovasc Surg 129:997-1005. 2005
    ..We sought to determine whether the use of antiarrhythmic medications is associated with a reduced rate of postoperative atrial tachyarrhythmia...
  7. ncbi Improving clinical outcomes in coronary artery bypass graft surgery
    Artyom Sedrakyan
    Johns Hopkins Bloomberg School of Public Health, 624 North Broadway, Suite 492, Baltimore, MD 21205, USA
    Am J Health Syst Pharm 62:S19-23. 2005
    ..This analysis was performed to further address concerns that aprotinin safety often outweighs the well-established transfusion reduction benefits...
  8. ncbi Surgeons may have introduced a new operative technique in African-American patients
    Tom Treasure
    J Health Serv Res Policy 12:2-3. 2007
  9. ncbi The evidence on the effectiveness of management for malignant pleural effusion: a systematic review
    Carol Tan
    Thoracic Unit, Guy's Hospital, St Thomas' Street, London SE1 9RT, United Kingdom
    Eur J Cardiothorac Surg 29:829-38. 2006
    ..Where thoracoscopy is unavailable bedside talc pleurodesis has a high success rate and is the next best option...
  10. ncbi Recursive partitioning-based preoperative risk stratification for atrial fibrillation after coronary artery bypass surgery
    Artyom Sedrakyan
    Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA
    Am Heart J 151:720-4. 2006
    ..The tree-based method may be a useful tool for clinicians who seek to determine who is more or less likely to benefit from aggressive arrhythmia prophylaxis...
  11. ncbi Video assisted thoracic surgery for treatment of pneumothorax and lung resections: systematic review of randomised clinical trials
    Artyom Sedrakyan
    Health Services Research Unit, Department of Public Health and Policy, London School of Hygiene and Tropical Medicine, London WC1E 7HT
    BMJ 329:1008. 2004
    ..As for lobectomy, further studies are needed to determine how it compares with thoracotomy...
  12. ncbi Postoperative chemotherapy for non-small cell lung cancer: A systematic review and meta-analysis
    Artyom Sedrakyan
    Health Services Research Unit, Department of Public Health and Policy, London School of Hygiene and Tropical Medicine, London, United Kingdom
    J Thorac Cardiovasc Surg 128:414-9. 2004
    ..Accordingly, we sought to determine whether postoperative chemotherapy is associated with improved survival compared with that after surgical intervention alone...
  13. ncbi Volume expansion with albumin decreases mortality after coronary artery bypass graft surgery
    Artyom Sedrakyan
    School of Medicine, Yale University, New Haven, CT, USA
    Chest 123:1853-7. 2003
    ..67 to 0.96). CONCLUSION: Colloid administration in CABG surgery was unrelated to patient characteristics. Albumin use appears to be associated with lower incidence of mortality after CABG surgery compared to nonprotein colloid use...
  14. ncbi Beta-blocker therapy and symptoms of depression, fatigue, and sexual dysfunction
    Dennis T Ko
    Section of Cardiovascular Medicine, Department of Medicine, Yale University School of Medicine, New Haven, CT 06520-8025, USA
    JAMA 288:351-7. 2002
    ..The risks of these adverse effects should be put in the context of the documented benefits of these medications...